Cargando…
Quantifying Conflict of Interest in the Choice of Anti-VEGF Agents
PURPOSE: To quantify the economic incentives associated with the choice of anti-VEGF drugs for retinal diseases. METHODS: An economic model was created based on the distribution of use and number of injections of bevacizumab (B), versus aflibercept or ranibizumab (AR); published Medicare reimburseme...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039845/ https://www.ncbi.nlm.nih.gov/pubmed/33854294 http://dx.doi.org/10.2147/OPTH.S298575 |